U.S. FDA says Evusheld may not protect against Omicron subvariant XBB.1.5
(Reuters) – The U.S. Food and Drug Administration said on Friday it does not expect AstraZeneca’s COVID-19 antibody cocktail Evusheld to provide protection against the Omicron subvariant XBB.1.5. The subvariant has been…
